皇家药店是生物制药创新的基金者,将在12月3日和4日出席投资者会议。 Royalty Pharma, a biopharm innovation funder, will present at investor conferences on Dec. 3rd and 4th.

Royalty Pharma 为生物制药创新提供资金以换取特许权使用费，该公司将在 12 月的两场投资者会议上发表演讲：12 月 3 日的 Evercore ISI HealthCONx 会议和 12 月 4 日的花旗 2024 年全球医疗保健会议。 Royalty Pharma, which funds biopharmaceutical innovations in exchange for royalties, will present at two investor conferences in December: the Evercore ISI HealthCONx Conference on December 3rd and Citi's 2024 Global Healthcare Conference on December 4th. 该公司的投资组合包括对超过35种商业产品的特许权使用费。 The company's portfolio includes royalties on over 35 commercial products. 专题介绍的网播将在皇家药店网站上提供,并存档至少30天。 Webcasts of the presentations will be available on Royalty Pharma's website and archived for at least 30 days.